T1	Participants 104 128	type 2 diabetic subjects
T2	Participants 449 474	type 2 diabetic subjects.
T3	Participants 503 569	Twenty type 2 diabetic subjects participated in a crossover trial.
T4	Participants 1674 1698	type 2 diabetic subjects
